Evidence map›Paper›PMID 31521143›Full record

ArticleBMC cancer2019

A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells - possible approaches to circumvent these phenomena.

Karolina Janik, Cezary Treda, Aneta Wlodarczyk, Joanna Peciak, Kamila Rosiak, Jolanta Zieba, Dagmara Grot, Adrianna Rutkowska, Roza Pawlowska, Waldemar Och and 2 more

Abstract read
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. TheExperimental biology and medicine (Maywood, N.J.) · 2020
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Karolina JanikDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Cezary TredaDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Aneta WlodarczykDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Joanna PeciakDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Kamila RosiakDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Jolanta ZiebaDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Dagmara GrotDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Adrianna RutkowskaDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Roza PawlowskaDepartment of Research and Development, Celther Polska Ltd., Milionowa 23, 93-193, Lodz, Poland.
Waldemar OchClinical Department of Neurosurgery, The Voivodal Specialistic Hospital in Olsztyn, Zolnierska 18, 10-561, Olsztyn, Poland.
Piotr RieskeDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Ewelina Stoczynska-FidelusDepartment of Tumor Biology, Medical University of Lodz, Chair of Medical Biology, Zeligowskiego 7/9, 90-752, Lodz, Poland. ewelina.stoczynska-fidelus@umed.lodz.pl.ORCID http://orcid.org/0000-0002-7779-3075

Funding

National Center for Research in Development (PL) POIG.01.04-00-10-037/11-00National Science Center (PL) 2016/21/D/NZ3/02616
6 · The paper itself

Abstract

backgroundGlioblastoma (GB) is considered one of the most lethal tumors. Extensive research at the molecular level may enable to gain more profound insight into its biology and thus, facilitate development and testing of new therapeutic approaches. Unfortunately, stable glioblastoma cell lines do not reflect highly heterogeneous nature of this tumor, while its primary cultures are difficult to maintain in vitro. We previously reported that senescence is one of the major mechanisms responsible for primary GB cells stabilization failure, to a lesser extent accompanied by apoptosis and mitotic catastrophe-related cell death.

methodsWe made an attempt to circumvent difficulties with glioblastoma primary cultures by testing 3 different approaches aimed to prolong their in vitro maintenance, on a model of 10 patient-derived tumor specimens.

resultsTwo out of ten analyzed GB specimens were successfully stabilized, regardless of culture approach applied. Importantly, cells transduced with immortalizing factors or cultured in neural stem cell-like conditions were still undergoing senescence/apoptosis. Sequential in vivo/in vitro cultivation turned out to be the most effective, however, it only enabled to propagate cells with preserved molecular profile up to 3

conclusionsIn the majority of primary glioma cultures, there has to be an imbalance towards apoptosis and senescence, following few weeks of rapid proliferation. Our results indicate that it has to be associated with the mechanisms other than maintenance of glioblastoma stem cells or dependence on proteins controlling cell cycle.

Indexed as

ApoptosisCellular SenescenceAnimalsBrain NeoplasmsCell Line, TumorCell Transformation, NeoplasticGene Expression ProfilingGenotypeGlioblastomaHumansMiceMutationPhenotypeApoptosisGlioblastomaImmortalizationIn vivo modelSenescence

Identifiers

PMID31521143
PMCPMC6744717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.